Sevoflurane at 1 MAC provides optimal myocardial protection during off-pump CABG

References

• Frabdorf J, De Hert S, Schlack W. Anesthesia and myocardial ischemia/reperfusion injury. Br J Anaeth. 2009;103:89–98.
   PubMedGoogle Scholar
• Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M, et al. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery. Anesthesiology. 2007;106:444–57.
   PubMed Web of Science ®Google Scholar
• Ceyhan D, Tanriverdi B, Bilir A. Comparison of the effects of sevoflurane and isoflurane on myocardial protection in coronary bypass surgery. Anadolu Kardiyol Derg. 2011; 11:257–62.
   PubMed Web of Science ®Google Scholar
• De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, et al. Effects of sevoflurane, desflurane, and propofol on recover of myocardial function after coronary surgery in elderl high-risk patients. Anesthesiology. 2003;99:314–23.
   PubMed Web of Science ®Google Scholar
• De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, et al. Choice of primary anesthetic regimen can influence intensive care unit stay after coronary surgery with cardiac bypass. Anesthesiology. 2004; 101:9–20.
   PubMed Web of Science ®Google Scholar
• Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Brit J Anaesth. 2007;99:624–31.
   PubMed Web of Science ®Google Scholar
• Zitta K, Meybohm P, Bein B, Ohnesorge H, Steinfath M, Scholz J, et al. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur J Pharmacol. 2010;645:39–46.
   PubMed Web of Science ®Google Scholar
• Bignami E, Landoni G, Gerli C, Testa V, Mizzi A, Fano G, et al. Sevoflurane vs. propofol in patients with coronary disease undergoing mitral surgery: a randomised study. Acta Anaesthesiol Scand. 2011;56:482–90.
   PubMed Web of Science ®Google Scholar
• Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, Ten Broecke PW, Stockman BA, et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg. 2006;103:289–96.
   PubMed Web of Science ®Google Scholar
• Conzen PF, Fischer S, Deter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology. 2003;99:826–33.
   PubMed Web of Science ®Google Scholar
• Bein B, Renner J, Caliebe D, Scholz J, Paris A, Fraund S, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg. 2005;100:610–6.
   PubMed Web of Science ®Google Scholar
• Nordenskjöld AM, Ahlström H, Eggers KM, Fröbert O, Jaffe AS, Venge P, et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem. 2012 Nov 26. [Epub aheCad of print].
   Google Scholar
• Røsjø H, Kravdal G, Høiseth AD, Jørgensen M, Badr P, Røysland R, et al. Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 Study. Clin Chem. 2012;58:1565–73.
   PubMed Web of Science ®Google Scholar
• McQueen MJ, Kavsak PA, Xu L, Shestakovska O, Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem. 2012 Oct 9. [Epub ahead of print].
   Google Scholar
• Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, et al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg. 2004;98:11–9.
   PubMed Web of Science ®Google Scholar
• Prabhakar H, Ali Z, Bithal PK, Rath GP, Singh D, Dash HH. Isoflurane and sevoflurane decrease entropy indices more than halothane at equal mac values. J Anesth. 2009;23:154–7.
   PubMed Web of Science ®Google Scholar
• Obal D, Preckel B, Scharbatke H, Müllenheim J, Höterkes F, Thämer V, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth. 2001;87:905–11.
   PubMed Web of Science ®Google Scholar
• Wiese AJ, Barter LS, Ilkiw JE, Kittleson MD, Pypendop BH. Cardiovascular and respiratory effects of incremental doses of dopamine and phenylephrine in the management of isoflurane-induced hypotension in cats with hypertrophic cardiomyopathy. Am J Vet Res. 2012;73:908–916.
   PubMed Web of Science ®Google Scholar
• Iida H, Ohata H, Iida M, Watanabe Y, Dohi S. Isoflurane and sevoflurane induce vasodilation of cerebral vessels via ATP-sensitive K+ channel activation. Anesthesiology. 1998;89:954–60.
   Google Scholar
• Larach DR, Schuler HG. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology. 1991;75:268–78.
   PubMed Web of Science ®Google Scholar
• Gravel NR, Searle NR, Taillefer J, Carrier M, Roy M, Gagnon L. Comparison of the hemodynamic effects of sevoflurane anesthesia induction and maintenance vs TIVA in CABG surgery. Can J Anaesth. 1999;46:240–6.
   PubMed Web of Science ®Google Scholar
• Yao YT, Li LH. Sevoflurane versus propofol for myocardial protection in patients undergoing coronary artery bypass grafting surgery: a meta-analysis of randomized controlled trials. Chin Med Sci J. 2009;24:133–41.
   PubMedGoogle Scholar
• Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth. 2006;53:906–18.
   PubMed Web of Science ®Google Scholar
• Venkatesh BG, Mehta Y, Kumar A, Trehan N. Comparison of sevoflurane and isoflurane in opcab surgery. Ann Card Anaesth. 2007;10:46–50.
   PubMedGoogle Scholar
• Gerhardt W, Katus H, Ravkilde J, Hamm C, Jørgensen PJ, Peheim E, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem. 1991;37: 1405–11.
   PubMed Web of Science ®Google Scholar
• van Geene Y, van Swieten HA, Noyez L. Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality. Interact Cardiovasc Thorac Surg. 2010;10: 413–6.
   PubMedGoogle Scholar
• Hashemzadeh K, Dehdilani M. Postoperative cardiac troponin I is an independent predictor of in-hospital death after coronary artery bypass grafting. J Cardiovasc Surg (Torino). 2009;50:403–9.
   PubMed Web of Science ®Google Scholar
• Amin AP, Mukhopadhyay E, Napan S, Mamtani M, Kelly RF, Kulkarni H. Value of early cardiac troponin I to predict long-term adverse events after coronary artery bypass graft surgery in patients presenting with acute coronary syndromes. Clin Cardiol. 2009;32:386–92.
   PubMed Web of Science ®Google Scholar
• Tzimas PG, Milionis HJ, Arnaoutoglou HM, Kalantzi KJ, Pappas K, Karfis E, et al. Cardiac troponin I versus creatine kinase-MB in the detection of postoperative cardiac events after coronary artery bypass grafting surgery. J Cardiovasc Surg (Torino). 2008;49:95–101.
   PubMed Web of Science ®Google Scholar
• Fellahi JL, Hedoire F, Le Manach Y, Monier E, Guillou L, Riou B. Determination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: a comparative study between coronary artery bypass graft, valve surgery, and combined cardiac surgery. Crit Care. 2007;11:R106.
   PubMedGoogle Scholar
• Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analyhsis encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989;159:1427–34.
   PubMed Web of Science ®Google Scholar
• LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides. 2005;26:944–56.
   PubMed Web of Science ®Google Scholar
• Seilhamer JJ, Arfsten A, Miller JA, Lundquist P, Scarborough RM, Lewicki JA, et al. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun. 1989;165:650–8.
   PubMed Web of Science ®Google Scholar
• Onuoha GN, Nicholls DP, Patterson A, Beringer T. Neuropeptide secretion in exercise. Neuropeptides. 1998; 32:319–25.
   PubMed Web of Science ®Google Scholar
• Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195–203.
   PubMed Web of Science ®Google Scholar
• Bruneau BG, de Bold AJ. Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc Res. 1994;28:1519–25.
   PubMed Web of Science ®Google Scholar